Bank of Montreal’s Insys Therapeutics, Inc. INSY Stock Holding History

Bank of Montreal’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-85,500	Closed	-$862K	–	4967
2018 Q3	$862K	Sell	85,500 -81,700	-49%	-$652K	﹤0.01%	2073
2018 Q2	$1.21M	Buy	167,200 +1,200	+0.7%	+$8.37K	﹤0.01%	1909
2018 Q1	$1M	Buy	166,000 +100,900	+155%	+$833K	﹤0.01%	1917
2017 Q4	$626K	Hold	65,100	–	–	﹤0.01%	2183
2017 Q3	$578K	Buy	65,100 +9,100	+16%	+$93.9K	﹤0.01%	2225
2017 Q2	$708K	Buy	+56,000	New	+$663K	﹤0.01%	2131
2016 Q2	–	Sell	-29,900	Closed	-$478K	–	4438
2016 Q1	$478K	Buy	+29,900	New	+$568K	﹤0.01%	2066

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Bank of Montreal's INSY Position: Q2 2019 in Review

Bank of Montreal sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 2,718 shares — an estimated $13K sold.

Bank of Montreal first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $2.15M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Bank of Montreal reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Bank of Montreal sold 2,718 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $13K.
Bank of Montreal first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
Bank of Montreal's Insys Therapeutics, Inc. position peaked at $2.15M in Q2 2015.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.